[Clinical evaluation of azithromycin for respiratory infectious diseases]
1First Department of Internal Medicine, Kurume University School of Medicine.
Abstract:
Azithromycin(AZM), an azalide macrolide with a 15-membered ring, is superior in cell/tissue penetration. Sustained pulmonary tissue concentrations are maintained which are higher than various MICs for major respiratory pathogens. Much research and clinical investigation has been done to evaluate the clinical efficacy of azithromycin abroad. In Japan, an optimal dose-finding pneumonia study was started in January, 1993, and a controlled comparative pneumonia study with clarithromycin was started in December of the same year. Patient compliance was excellent with the 3-day once daily regimen of AZM(500 mg). Azithromycin has been demonstrated to be highly clinically useful based on high efficacy (including the elderly population) and an established safety profile.
Insights
Azithromycin (AZM) offers superior penetration and sustained lung concentrations, proving highly effective for pneumonia treatment. A 3-day regimen showed excellent patient compliance and a strong safety profile.
Area of Science:
- Pharmacology
- Microbiology
- Clinical Medicine
Context:
- Azithromycin (AZM), a 15-membered ring azalide macrolide, exhibits enhanced cell and tissue penetration capabilities.
- Sustained pulmonary tissue concentrations of AZM exceed the minimum inhibitory concentrations (MICs) for key respiratory pathogens.
- Extensive research has evaluated the clinical efficacy of azithromycin globally.
Purpose:
- To assess the clinical efficacy and safety of azithromycin for pneumonia treatment.
- To compare azithromycin with clarithromycin in a controlled pneumonia study.
- To determine an optimal dosage regimen for azithromycin in pneumonia patients.
Summary:
- A 3-day, once-daily regimen of azithromycin (500 mg) demonstrated excellent patient compliance in Japanese clinical trials.
- High efficacy was observed, including in the elderly population, supporting azithromycin's clinical utility.
- Azithromycin possesses a well-established safety profile, making it a valuable therapeutic option.
Impact:
- Azithromycin provides a highly effective and safe treatment option for respiratory infections like pneumonia.
- The drug's pharmacokinetic properties, including sustained tissue concentrations, contribute to its therapeutic success.
- Clinical studies confirm the benefits of azithromycin, supporting its use in diverse patient groups.
Related Concept Videos
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Respiratory Syncytial Virus Disease


